News archive

Filter by: Reset

February 2025

- 17 February 2025
- Crown Bioscience
Crown Bioscience Completes Merger with Indivumed Services

Crown Bioscience completes Indivumed Services merger, offering enhanced drug development solutions globally and retiring the Indivumed brand.
- 11 February 2025
- Crown Bioscience
Crown Bioscience Germany GmbH Achieves Continued CAP 15189:2022 Accreditation

Crown Bioscience's Hamburg site secures continued CAP ISO 15189:2022 accreditation, showcasing its commitment to quality in laboratory services.

- 11 December 2024
- Crown Bioscience
Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership

Crown Bioscience wins 2024 Fierce CRO Award for excellence in client service, underscoring its commitment to innovative drug development partnerships.
- 10 December 2024
- Crown Bioscience
Crown Bioscience Wins BioTech Breakthrough Award for Drug Development Innovation

Crown Bioscience's OrganoidXplore receives BioTech Award, revolutionizing oncology with advanced preclinical screening.
- 3 December 2024
- KBI Biopharma
KBI Biopharma to Lead Development and Manufacturing of Alanis Therapeutics’ Antagonistic Monoclonal Antibody Candidate

KBI Biopharma Selected as CDMO of Choice to Fast-Track Development of Pre-Clinical Antibody for Blood Cancers Using SUREmAbTM Technology

- 30 October 2024
- Crown Bioscience
Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biops...

Crown Bioscience, part of JSR Life Sciences, joins a €1.75M Eurostars project to develop a novel liquid biopsy for prostate cancer, enhancing treatment.
- 1 October 2024
- Crown Bioscience
Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

Crown Bioscience enhances its global presence with the expansion of its Singapore facility, featuring cutting-edge oncology models and imaging capabilities.

- 17 September 2024
- JSR Corporation
JSR Life Sciences to Launch Amsphere™ A+, a Next-Generation Protein A Resin for Antibody Drug Purification

Amsphere™ A+ enhances antibody drug production with advanced polymer technology and high binding capacity, debuting at BPI 2024 and BioJapan.

- 20 August 2024
- Crown Bioscience
Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development

Crown Bioscience announces a strategic partnership with Clinical Trial & Consulting Services (CTI), a renowned global full-spectrum research service provider, to bolster oncology-focused consulting...

- 23 July 2024
- KBI Biopharma
Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Phar...

Extension reinforces KBI’s commitment to forge long-term partnerships to successfully address complex clinical development and commercialization challenges.

- 20 June 2024
- MBL
MBL Co-sponsors a Seminar on MEBRIGHT™ genitalium Plus DR Kit at the 98th JAID / the 72nd JSC Conference

MBL to co-sponsor a seminar on MEBRIGHT™ genitalium Plus DR Kit at the 98th JAID/72nd JSC Conference, focusing on STD treatment advancements. Learn more on June 27th, 2024.

- 24 May 2024
- Crown Bioscience
Crown Bioscience Enters Global Agreement with Shanghai Model Organisms Center

Crown Bioscience announces the completion of a global collaboration agreement with the Shanghai Model Organism Center (SMOC). This five-year agreement extends the existing partnership and will prov...

1 of 23